Zymeworks Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ZYME Nasdaq 2834 www.zymeworks.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zymeworks Inc.

Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026 - Jul 16th, 2026 4:00 am
Truist Remains Bullish on Zymeworks (ZYME) – Here’s Why - Jul 15th, 2026 2:33 am
Zymeworks (ZYME) Stock Looks Fully Valued Despite Its 205% Three Year Run - Jul 1st, 2026 4:10 am
Is Zymeworks Inc. (ZYME) Stock an Undervalued Biotech Opportunity With Oncology Growth Ahead? - Jun 30th, 2026 7:21 am
Theravance Stock Down 3% After Zymeworks Announces Buyout - Jun 30th, 2026 6:54 am
Zymeworks agrees to buy Theravance Biopharma for $929m - Jun 30th, 2026 2:26 am
Sector Update: Healthcare Stocks Higher Late Afternoon - Jun 29th, 2026 1:59 pm
Zymeworks To Buy Theravance Biopharma In $929M Deal – A Look At What This Deal Means For TBPH Shareholders - Jun 29th, 2026 6:44 am
Zymeworks to Buy Theravance for Lung Disease Drug. Both Stocks Are Sliding. - Jun 29th, 2026 6:39 am
Zymeworks to Acquire Theravance Biopharma in $929 Million Deal - Jun 29th, 2026 4:19 am
Zymeworks to Acquire Theravance Biopharma, Inc. - Jun 29th, 2026 4:00 am
THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT - Jun 29th, 2026 4:00 am
Theravance, after clinical setbacks, agrees to $929M buyout - Jun 29th, 2026 2:42 am
Gandeeva and Zymeworks Use Cryo-EM to Accelerate Antibody Drug Discovery - Jun 18th, 2026 6:00 am
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Amid US-Iran Ceasefire - Jun 15th, 2026 6:56 am
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - Jun 14th, 2026 4:05 pm
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock - May 14th, 2026 2:05 pm
Zymeworks Announces Participation in Upcoming Investor Conferences - May 13th, 2026 4:00 am
Here's What Analysts Are Forecasting For Zymeworks Inc. (NASDAQ:ZYME) After Its First-Quarter Results - May 11th, 2026 6:32 am
A Look At Zymeworks (ZYME) Valuation After Earnings Miss And Key FDA And Capital Return Updates - May 9th, 2026 3:24 pm